Atlas Trials

Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer

Clinical trial NCT07667400 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07667400
Sponsor
National Cancer Institute (NCI)
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Head and Neck CancerHead and Neck Squamous Cell CarcinomaParanasal Sinus NeoplasmsNasopharyngeal CarcinomaOropharyngeal Squamous Cell CarcinomaHypopharyngeal CancerCarcinoma of LarynxOral Squamous Cell CarcinomaSalivary Gland CancerAdenoid Cystic CarcinomaProstate CancerMetastatic Castration Resistant Prostate Cancer
Start date
2026-08-26
Primary completion
2036-10-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.